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strategy for patients with many end-stage pulmonary dis-
eases.1 However, the mortality rate is still high in the early
phase of lung transplantation, and primary graft dysfunc-
tion is a major cause of morbidity and mortality that occurs
early in the post-transplantation period due to ischemia-
reperfusion injury (IRI). Because primary graft dysfunction
is presumed to be mainly caused by IRI, it is important to
develop effective therapeutic prevention and treatment
strategies for lung transplantation.
Ischemic preconditioning (IPC), which consists of brief
and repetitive periods of IR prior to a sustained organ
ischemia, was first discovered in 1986 by Murry et al.2 Many
studies have demonstrated that IPC may be the most
powerful innate protective mechanism against IRI and can
attenuate the sustained IRI in several organs such as the
heart, kidney, liver, and brain.3 Despite a number of sub-
stances such as adenosine, prostaglandins, nitric oxide, and
some cytokines being proven effective in both the treat-
ment of IRI and the protection of IPC,4 the exact informa-
tion about the mechanism by which this protection in lung
IRI works is still limited and needs further discussion.* Corresponding author. Department of Thoracic Surgery, First
Affiliated Hospital of Zhengzhou University, Zhengzhou 450052,
Henan, China.
E-mail address: lbyldl@gmail.com (D. Liu).
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http://dx.doi.org/10.1016/j.jfma.2013.06.015Autophagy is an evolutionary highly conversed process
among all eukaryotes ranging from yeast to mammals. The
functional relationship between autophagy and cellular
death or survival is complicated in that, in several situa-
tions, autophagy promotes survival under conditions of
stress and starvation, whereas in other cellular situations,
autophagy constitutes an alternative pathway to cellular
demise (autophagic cell death). Although increasing
attention has been focused on the functions of autophagy,
there is no consensus about its role in prosurvival or pro-
death. We propose the hypothesis that IPC provides pro-
tection against lung IRI partly by stimulating autophagy. Our
hypothesis indicates that autophagy may be a new poten-
tial therapeutic target for lung IRI.
Many studies have shown that autophagy can be induced
by various cellular conditions in IRI, including energy star-
vation, oxidative stress, endoplasmic reticulum stress, and
inflammation. Moreover, it is reported that activation of
autophagy by drugs may be a fundamental process that
enhances the organ’s tolerance to ischemia.5 Because
ischemia induces a lack of nutrients and metabolic stress,
there is no doubt that autophagy is activated after lung IRI
to play a role as a survival mechanism degrading long-lived
proteins and dysfunctional organelles.
In fact, many reports have indicated that autophagy is
an important mechanism between IPC and IRI in several
organs. In the process of cardiac IRI, autophagy has been
proven to be an important element of numerous defense& Formosan Medical Association. All rights reserved.
678 M. Gao, D. Liumechanisms activated by IPC.6 Moreover, in cerebral
ischemia, autophagy may participate in IPC-induced neu-
roprotection and provide a means of neuroprotection
against ischemia.7 Furthermore, various studies have
proven that regulation of autophagy can significantly
enhance or decrease the protective effect of IPC against
IRI. In a rat model of cerebral IPC, the different results,
which were obtained by intracerebral ventricle infusion
inducer of the autophagy inhibitors 3-methyladeninie and
bafilomycin A1 or the autophagy inducer rapamycin,
demonstrate that autophagy activation during IPC offers a
remarkable neuroprotective effect to subsequent fatal
ischemic insult.8 In other animal models, autophagy acti-
vation during IPC offers a protective effect to a subsequent
fatal ischemic insult. Thus, many experiments suggest that
autophagy activated during IPC is essential for the protec-
tion against IRI.
These studies have suggested that autophagy can act as
a survival pathway in the process of IPC against IRI. Previous
studies have shown that IPC can reduce the damage of lung
IRI through several pathways in experimental research9 and
clinical application.10 Therefore, we speculate that auto-
phagy may play a role as a survival pathway during IPC
against lung IRI.
In recent years, increasing attention has been focused
on the role of autophagy during IPC against IRI. Although
the mechanism of IPC and its clinical application should be
further explored, at least it provides us a potential target in
the future prevention of lung IRI.Acknowledgments
This study was supported by the Youth Innovation Fund
Project of the First Affiliated Hospital of Zhengzhou
University.References
1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM,
Hertz MI, et al. Registry of the International Society for Heart
and Lung Transplantation: twenty-third official adult lung and
heart-lung transplantation reportd2006. J Heart Lung Trans-
plant 2006;25:880e92.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with
ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation 1986;74:1124e36.
3. Churchill EN, Ferreira JC, Brum PC, Szweda LI, Mochly-Rosen D.
Ischaemic preconditioning improves proteasomal activity and
increases the degradation of deltaPKC during reperfusion.
Cardiovasc Res 2010;85:385e94.
4. Huang Y, Shan J, Wang C, Ma J, Li D, Li L, et al. Can ischemic
preconditioning alone really protect organs from ischemia
reperfusion injury in transplantation. Transpl Immunol 2009;
20:127e31.
5. Huang C, Liu W, Perry CN, Yitzhaki S, Lee Y, Yuan H, et al.
Autophagy and protein kinase C are required for car-
dioprotection by sulfaphenazole. Am J Physiol Heart Circ
Physiol 2010;298:H570e9.
6. Huang C, Yitzhaki S, Perry CN, Liu W, Giricz Z, Mentzer Jr RM,
et al.Autophagy inducedby ischemicpreconditioning is essential
for cardioprotection. J Cardiovasc Transl Res 2010;3:365e73.
7. Park HK, Chu K, Jung KH, Lee ST, Bahn JJ, Kim M, et al.
Autophagy is involved in the ischemic preconditioning. Neu-
rosci Lett 2009;451:16e9.
8. Sheng R, Zhang LS, Han R, Liu XQ, Gao B, Qin ZH. Autophagy acti-
vation is associated with neuroprotection in a rat model of focal
cerebral ischemic preconditioning. Autophagy 2010;6:482e94.
9. Jun N, Ke J, Gang C, Lin C, Jinsong L, Jianjun W. The protective
effect of ischemic preconditioning associated with altered
gene expression profiles in rat lung after reperfusion. J Surg
Res 2011;168:281e93.
10. Lin LN, Wang LR, Wang WT, Jin LL, Zhao XY, Zheng LP, et al.
Ischemic preconditioning attenuates pulmonary dysfunction
after unilateral thigh tourniquet-induced ischemia-reperfu-
sion. Anesth Analg 2010;111:539e43.
